Journal of Business Chemistry January 2008

While chemistry has never been short of inventions,the commercialization of these inventions into innovations requires a completely different set of skills. Many of the problems occurring in this process no longer deal with natural sciences alone but are rather related to topics from the field of business administration. However,natural scientists often lack a profound economic […]

First of all what is the meaning of REACh? REACh stands for Registration, Evaluation, Authorisation and Restriction of Chemicals and is the new Chemicals Regulation of the European Parliament and Council which entered into force on June 1, 2007. The background of REACh´s coming into force is that our current European chemical system has a […]

Abstract Literature has widely acknowledged that creating a tight network of collaborations is an unavoidable strategy for innovative biotech firms. However, few contributions have focused so far on how collaborations along the bio-pharmaceutical innovation process are organised in practice. The paper attempts to cover this gap by investigating, on a large empirical base which covers […]

After a period of consolidation, the European biotech industry faces new challenges in the course of increasing internationalization, especially in terms of the EU Eastern enlargement. On one hand, the accession of the new member states opens the emergence of new research, production and sales opportunities. On the other hand, the increasing competitive pressure may […]

The first dark clouds are gathering on the economic horizon of the chemical industry and may cause an unattractive dip in otherwise impressive growth. With the oil price remaining high, concerns that global economic growth is cooling and ever fiercer competition, the outlook is gloomy. There is also uncertainty about the reform of the European […]